We are live on
!
Find out more
SCP
Shorepoint Capital Partners Portfolio holdings
AUM
$503M
This Fund
S&P 500
This Quarter
Est. Return
+2.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$1.38M
(-0.78%)
Cap. Flow
-$5.75M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
31.53%
Holding
90
New
4
Increased
17
Reduced
60
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHI
Calamos Convertible Opportunities and Income Fund
CHI
|
+$831K |
| 2 |
EFT
Eaton Vance Floating-Rate Income Trust
EFT
|
+$812K |
| 3 |
Occidental Petroleum
OXY
|
+$716K |
| 4 |
Alcon
ALC
|
+$707K |
| 5 |
Tapestry
TPR
|
+$545K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameriprise Financial
AMP
|
+$949K |
| 2 |
Apple
AAPL
|
+$777K |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$772K |
| 4 |
Kraft Heinz
KHC
|
+$634K |
| 5 |
VF Corp
VFC
|
+$503K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.41% |
| 2 | Financials | 11.09% |
| 3 | Technology | 10.86% |
| 4 | Industrials | 8.15% |
| 5 | Consumer Discretionary | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares Core S&P Small-Cap ETF
IJR
$110B
| $1.33M | 0.76% |
17,035
-144
| -0.8% | -$11.2K |
|
52
Cognizant
CTSH
$23.8B
| $1.18M | 0.67% |
18,618
-160
| -0.9% | -$10.5K |
|
53
Arch Capital
ACGL
$37.2B
| $1.01M | 0.57% |
27,154
-3,184
| -10% | -$109K |
|
54
Lockheed Martin
LMT
$134B
| $1.01M | 0.57% |
2,770
+183
| +7% | +$61.2K |
|
|
RTN
55
DELISTED
Raytheon Company
RTN
| $964K | 0.55% |
5,544
-853
| -13% | -$153K |
|
56
Pfizer
PFE
$144B
| $961K | 0.55% |
23,372
| – | – |
|
|
AGN
57
DELISTED
Allergan plc
AGN
| $927K | 0.53% |
5,536
+231
| +4% | +$32K |
|
58
Amazon
AMZN
$2.48T
| $889K | 0.51% |
9,380
-680
| -7% | -$63.3K |
|
59
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $864K | 0.49% |
22,225
+70
| +0.3% | +$2.68K |
|
60
Stryker
SYK
$133B
| $858K | 0.49% |
4,175
-103
| -2% | -$19.7K |
|
|
CHI
61
Calamos Convertible Opportunities and Income Fund
CHI
$994M
| $840K | 0.48% |
+80,000
| New | +$831K |
|
|
EAD
62
Allspring Income Opportunities Fund
EAD
$373M
| $824K | 0.47% |
100,000
+50,000
| +100% | +$401K |
|
|
EFT
63
Eaton Vance Floating-Rate Income Trust
EFT
$284M
| $809K | 0.46% |
+60,000
| New | +$812K |
|
|
DISCK
64
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $780K | 0.44% |
27,412
-1,300
| -5% | -$35.3K |
|
65
Deere & Co
DE
$173B
| $769K | 0.44% |
4,642
-275
| -6% | -$42.8K |
|
66
Citizens Financial Group
CFG
$30.8B
| $752K | 0.43% |
21,269
-1,585
| -7% | -$55.2K |
|
|
67
Alcon
ALC
$33.7B
| $748K | 0.43% |
+12,051
| New | +$707K |
|
68
Lowe's Companies
LOW
$122B
| $736K | 0.42% |
7,294
-490
| -6% | -$51.7K |
|
|
FDC
69
DELISTED
First Data Corporation
FDC
| $689K | 0.39% |
25,458
-1,760
| -6% | -$45.8K |
|
70
Schwab US Broad Market ETF
SCHB
$42.9B
| $688K | 0.39% |
58,488
-2,802
| -5% | -$32.4K |
|
71
Biogen
BIIB
$30.4B
| $684K | 0.39% |
2,925
+1,033
| +55% | +$239K |
|
72
Adobe
ADBE
$99B
| $666K | 0.38% |
2,259
+2
| +0.1% | +$555 |
|
73
Honeywell
HON
$78.3B
| $644K | 0.37% |
3,913
| – | – |
|
74
Alibaba
BABA
$276B
| $611K | 0.35% |
3,608
+98
| +3% | +$16.9K |
|
75
Chevron
CVX
$374B
| $523K | 0.3% |
4,199
-615
| -13% | -$74.4K |
|
Similar funds
VBFG
JWM
FNC
OHWA
ODG
GP
SCA
SFPM
Shorepoint Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Shorepoint Capital Partners held 90 positions worth $175M, down 0.78% from $177M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Shorepoint Capital Partners withdrew a net $5.75M in Q2 2019, closing 3 positions and reducing 60 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $772K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Shorepoint Capital Partners opened a new position in Calamos Convertible Opportunities and Income Fund worth $840K.
- Shorepoint Capital Partners's largest Q2 2019 buy was Calamos Convertible Opportunities and Income Fund: 80,000 shares worth $840K.
- Shorepoint Capital Partners added most to Occidental Petroleum in Q2 2019, an estimated $716K increase.
- Shorepoint Capital Partners's biggest Q2 2019 reduction was Ameriprise Financial, cutting an estimated $949K.
- Shorepoint Capital Partners fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $772K.
- Shorepoint Capital Partners's ten largest holdings make up 32% of its $175M portfolio in Q2 2019.
- Shorepoint Capital Partners opened 4 new positions and closed 3 in Q2 2019.
- Shorepoint Capital Partners's portfolio value fell 0.78% quarter-over-quarter to $175M.
Based on Shorepoint Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.